BNP Paribas Financial Markets’s Cellectis CLLS Stock Holding History

BNP Paribas Financial Markets’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Sell	40,100 -900	-2%	-$3.2K	﹤0.01%	4456
2026 Q1	$130K	Sell	41,000 -300	-0.7%	-$1.15K	﹤0.01%	4244
2025 Q4	$200K	Hold	41,300	–	–	﹤0.01%	4057
2025 Q3	$118K	Hold	41,300	–	–	﹤0.01%	4223
2025 Q2	$62.4K	Buy	41,300 +3,200	+8%	+$4.62K	﹤0.01%	4169
2025 Q1	$47.2K	Buy	38,100 +15,700	+70%	+$23.3K	﹤0.01%	4306
2024 Q4	$40.3K	Buy	22,400 +4,000	+22%	+$7.46K	﹤0.01%	4513
2024 Q3	$39.4K	Buy	18,400 +1,700	+10%	+$3.69K	﹤0.01%	3661
2024 Q2	$31.2K	Sell	16,700 -100	-0.6%	-$262	﹤0.01%	3573
2024 Q1	$44.5K	Buy	16,800 +1,000	+6%	+$2.77K	﹤0.01%	3583
2023 Q4	$48.7K	Buy	15,800 +4,856	+44%	+$11.5K	﹤0.01%	3571
2023 Q3	$17.3K	Buy	10,944 +9,727	+799%	+$19K	﹤0.01%	3578
2023 Q2	$2.39K	Buy	+1,217	New	+$2.33K	﹤0.01%	3718
2023 Q1	–	Sell	-166	Closed	-$349	–	3881
2022 Q4	$349	Buy	+166	New	+$376	﹤0.01%	3887
2022 Q3	–	Sell	-229	Closed	-$648	–	4784
2022 Q2	$648	Buy	+229	New	+$806	﹤0.01%	3940

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

BNP Paribas Financial Markets's CLLS Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Cellectis (CLLS) stake by 2.2% in Q2 2026, selling an estimated $3.2K and leaving 40,100 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #4456.

BNP Paribas Financial Markets first reported a position in CLLS in Q2 2022 and has held it in 15 quarters since. The position peaked at $200K in Q4 2025. 26 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

BNP Paribas Financial Markets held 40,100 shares of Cellectis worth $120K as of Q2 2026.
BNP Paribas Financial Markets sold 900 Cellectis shares in Q2 2026, an estimated $3.2K.
Cellectis made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4456 holding.
BNP Paribas Financial Markets first reported a position in Cellectis in Q2 2022 and has held it in 15 quarters since.
BNP Paribas Financial Markets's Cellectis position peaked at $200K in Q4 2025.
26 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.